DKSH’s Business Unit Healthcare, the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia, has signed an agreement with GlaxoSmithKline (GSK) to provide contract sales services in both private clinics and trade channel for its antibiotic product line.
DKSH’s Business Unit Healthcare in Hong Kong has the largest sales team in the industry to provide sales and promotion services for clients, now including GSK.
“We look forward to a successful partnership for both companies and to help patients to gain access to quality medicine,” said Sally Storey, vice president and general manager, GlaxoSmithKline (Hong Kong) Limited.
“We are extremely excited to provide Market Expansion Services to GSK and to supporting them with our extensive commercial capabilities,” added Richard Holloway, vice president, DKSH Healthcare, Hong Kong. “To outsource sales and distribution service as part of its product portfolio enables GSK to concentrate on its core competencies while minimizing cost. Outsourcing is a global trend and will continue to be significant when pharmaceutical companies require expert support along the value chain.”
The new partnership will further strengthen DKSH’s market position in Hong Kong while contributing incrementally to the Group’s overall earnings and profitability over time.